Belite Bio, Inc Capital Expenditure
| Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|
| Capital Expenditure | ($20.0K) | ($74.0K) | ($394.0K) | ($63.0K) |
Belite Bio, Inc (BLTE) Capital Expenditure comparison analysis
General
LTM Capital Expenditure
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
BLTE key stats
| Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|
% growth | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% | 0.0 0.0% |
| Cost of Goods Sold (COGS) | 0.0 | 0.0 | 0.2 | 0.4 |
% margin | (0.0) 0.0% | (0.0) 0.0% | (0.2) 0.0% | (0.4) 0.0% |
| Operating Expenses | 5.7 | 9.8 | 12.8 | 31.7 |
| Research & Development Expenses (R&D) | 3.7 | 7.4 | 8.9 | 24.8 |
| Selling, General & Administrative Expenses (SG&A) | 2.1 | 2.4 | 4.0 | 6.8 |
% margin | (5.7) 0.0% | (9.8) 0.0% | (12.8) 0.0% | (31.7) 0.0% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.1 |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 |
| Pre-tax Income | (5.8) | (9.7) | (12.6) | (31.6) |
% effective tax rate | 0.0 (0.0%) | 0.1 (1.3%) | (0.2) 1.4% | 0.0 (0.0%) |
% margin | (5.8) 0.0% | (9.8) 0.0% | (12.5) 0.0% | (31.6) 0.0% |
| EPS | (0.24) | (0.41) | (0.62) | (1.19) |
| Diluted EPS | (0.24) | (0.41) | (0.62) | (1.19) |
% margin | (5.7) 0.0% | (9.6) 0.0% | (12.4) 0.0% | (31.5) 0.0% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
FAQ
1) What is Belite Bio, Inc's Capital Expenditure?
As of today, Belite Bio, Inc's last 12-month Capital Expenditure is $0.0, based on the financial report for Sep 30, 2024 (Q3’2024).
2) What is Belite Bio, Inc's Capital Expenditure growth rate?
Over the last year, Belite Bio, Inc's Capital Expenditure growth was (100.0%). The average annual Capital Expenditure growth rates for Belite Bio, Inc have been (100.0%) over the past three years, (100.0%) over the past five years.
3) Is Belite Bio, Inc's Capital Expenditure growth rate Good?
Over the last year, Belite Bio, Inc's Capital Expenditure growth was (100.0%), which is lower than industry growth of (0.6%). It indicates that Belite Bio, Inc's Capital Expenditure growth is Good.